Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Colon Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Tao Zhang, MD) · woodyhom@yahoo.com · +86-13918805942

Study leads

Ren Zhao, PhD
Principal Investigator
Ruijin Hosipital, Shanghai Jiao Tong University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery

Metastatic Colon Carcinoma · Stage IV Colon Cancer AJCC v8 · Stage IVA Colon Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Hamilton, United States · Lakewood, United States

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors · Triple Negative Breast Cancer (TNBC) · HR+ Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Houston, United States

The Florida ASCENT Study

Cancer · Food Deprivation · Food Habits

Abroad (travel likely)Recruiting

Gainesville, United States